These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 32496536)

  • 1. Severe Acute Respiratory Syndrome Coronavirus 2 Human Challenge Trials: Too Risky, Too Soon.
    Dawson L; Earl J; Livezey J
    J Infect Dis; 2020 Jul; 222(3):514-516. PubMed ID: 32496536
    [No Abstract]   [Full Text] [Related]  

  • 2. Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines: Setting Expectations Appropriately.
    Heininger U
    Pediatr Infect Dis J; 2020 Jul; 39(7):e123-e124. PubMed ID: 32427644
    [No Abstract]   [Full Text] [Related]  

  • 3. Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2.
    Plotkin SA
    J Pediatric Infect Dis Soc; 2020 Nov; 9(5):517-518. PubMed ID: 32744616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges in evaluating SARS-CoV-2 vaccines during the COVID-19 pandemic.
    Abu-Raya B; Gantt S; Sadarangani M
    CMAJ; 2020 Aug; 192(34):E982-E985. PubMed ID: 32646869
    [No Abstract]   [Full Text] [Related]  

  • 5. A vaccine is not too far for COVID-19.
    Patel SK; Pathak M; Tiwari R; Yatoo MI; Malik YS; Sah R; Rabaan AA; Sharun K; Dhama K; Bonilla-Aldana DK; Rodriguez-Morales AJ
    J Infect Dev Ctries; 2020 May; 14(5):450-453. PubMed ID: 32525830
    [No Abstract]   [Full Text] [Related]  

  • 6. COVID-19 vaccines: early success and remaining challenges.
    Bar-Zeev N; Inglesby T
    Lancet; 2020 Sep; 396(10255):868-869. PubMed ID: 32896290
    [No Abstract]   [Full Text] [Related]  

  • 7. ChAdOx1 nCoV-19 vaccine for SARS-CoV-2.
    Lodge A
    Lancet; 2020 Nov; 396(10261):1486. PubMed ID: 33160564
    [No Abstract]   [Full Text] [Related]  

  • 8. ChAdOx1 nCoV-19 vaccine for SARS-CoV-2.
    Chauhan A; Agarwal A; Jaiswal N; Singh M
    Lancet; 2020 Nov; 396(10261):1485-1486. PubMed ID: 33160563
    [No Abstract]   [Full Text] [Related]  

  • 9. COVID-19 disrupts vaccine delivery.
    Nelson R
    Lancet Infect Dis; 2020 May; 20(5):546. PubMed ID: 32311326
    [No Abstract]   [Full Text] [Related]  

  • 10. ChAdOx1 nCoV-19 vaccine for SARS-CoV-2 - Authors' reply.
    Voysey M; Pollard AJ
    Lancet; 2020 Nov; 396(10261):1486-1487. PubMed ID: 33160565
    [No Abstract]   [Full Text] [Related]  

  • 11. Developing Covid-19 Vaccines at Pandemic Speed.
    Lurie N; Saville M; Hatchett R; Halton J
    N Engl J Med; 2020 May; 382(21):1969-1973. PubMed ID: 32227757
    [No Abstract]   [Full Text] [Related]  

  • 12. Covid-19 vaccines: Should we allow human challenge studies to infect healthy volunteers with SARS-CoV-2?
    McPartlin SO; Morrison J; Rohrig A; Weijer C
    BMJ; 2020 Nov; 371():m4258. PubMed ID: 33168564
    [No Abstract]   [Full Text] [Related]  

  • 13. A Call for a Three-Tiered Pandemic Public Health Strategy in Context of SARS-CoV-2.
    Hanley BP; Keen S; Church G
    Rejuvenation Res; 2020 Aug; 23(4):281-283. PubMed ID: 32539623
    [No Abstract]   [Full Text] [Related]  

  • 14. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
    Lambert PH; Ambrosino DM; Andersen SR; Baric RS; Black SB; Chen RT; Dekker CL; Didierlaurent AM; Graham BS; Martin SD; Molrine DC; Perlman S; Picard-Fraser PA; Pollard AJ; Qin C; Subbarao K; Cramer JP
    Vaccine; 2020 Jun; 38(31):4783-4791. PubMed ID: 32507409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Race to Develop a COVID-19 Vaccine.
    Am J Nurs; 2020 Oct; 120(10):14-15. PubMed ID: 32976132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Covid-19: Vaccine trials need more transparency to enable scrutiny and earn public trust, say experts.
    Mahase E
    BMJ; 2020 Oct; 371():m4042. PubMed ID: 33093065
    [No Abstract]   [Full Text] [Related]  

  • 17. Riding the coronacoaster of uncertainty.
    The Lancet Infectious Diseases
    Lancet Infect Dis; 2020 Jun; 20(6):629. PubMed ID: 32422202
    [No Abstract]   [Full Text] [Related]  

  • 18. Building Trust to Achieve Confidence in COVID-19 Vaccines.
    Opel DJ; Salmon DA; Marcuse EK
    JAMA Netw Open; 2020 Oct; 3(10):e2025672. PubMed ID: 33079194
    [No Abstract]   [Full Text] [Related]  

  • 19. The Covid-19 Vaccine-Development Multiverse.
    Heaton PM
    N Engl J Med; 2020 Nov; 383(20):1986-1988. PubMed ID: 32663910
    [No Abstract]   [Full Text] [Related]  

  • 20. [Not Available].
    Nau JY
    Rev Med Suisse; 2020 Jun; 16(696):1176-1177. PubMed ID: 32496711
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.